← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

4,000

Price

$0

Filed

Jun 23

Insider

Name

Arbuckle Stuart A

Title

CIK

0001557290

Roles

Director

Transaction Details

Transaction Date

2025-06-18

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date.

Filing Info

Accession No.

0001104659-25-061710

Form Type

4

Issuer CIK

0001649904

Arbuckle Stuart A's History

Date Ticker Type Value
2026-02-06 PRAX A $0
2026-02-06 PRAX A $0
2026-02-06 PRAX A $0
2026-01-05 ALNY A $0
2025-07-01 VRTX F $16.8M
2025-06-24 RYTM A $0
2025-06-24 RYTM A $0
2025-06-18 RYTM M
2025-06-18 RYTM M $0
2025-05-13 VRTX A $0

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01